Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucentis in Chilean DME patients
NCT02140411Phase 4Completed
- Sponsor
- Novartis
- Start
- Apr 2015
- Primary completion
- Dec 2016
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab in diabetic macular edema (DME), sponsored by Novartis. Started Apr 2015; status: completed.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02140411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02140411.